ImmunologybioRxiv
Improved CD4 T-cell profile and inflammatory levels in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination.
I. Herrero-Fernandez, I. Rosado-Sanchez, M. Genebat…·Y. M. Pacheco
The paper examines how maraviroc-containing therapy affects CD4 T-cell profiles and inflammation in HIV patients, linking these factors to improved HBV vaccine response.
DOI 10.1186/s12967-018-1617-1